Genomes.io
PrivateLast Round
Strategic
Jun 18, 2025
Est. Valuation
$8.36M
Total Funding Raised
$21.62M
Company Overview
Genomes.io is a biotechnology company that provides a private and secure DNA data bank allowing users to control and monetize their genomic data.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Data Protection, Precision Medicine, Blockchain Infrastructure, Digital Identity
Business Model
B2B2C
Customer Profile
Data as a Service, Usage-Based SaaS, Services & Consulting, Hardware Sales
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genomes.io Comparables
Compare Genomes.io with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GenoBank.io | 88% | |
| Shivom | 80% | |
| EncrypGen | 80% |
Genomes.io Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jun 18, 2025 | ||||
| VC Round | Jun 12, 2024 | ||||
| Strategic | Aug 21, 2023 | ||||
| Crowdfunding | Mar 14, 2023 | ||||
| Crowdfunding | Jan 30, 2020 | ||||
Crowdfunding | Sep 30, 2019 |
Genomes.io Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Consensys Mesh | Accelerator |
| Modular Capital | VC Round |
| GEM Digital Limited | Strategic |
| Pantera Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 58% MoM, reaching 9.2K.
- Apr 18, 2026
Monthly visitors grew 79% MoM, reaching 3.4K.
Genomes.io Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Genomes.io's valuation, stock price, and market status.
Is Genomes.io a public or private company?
Genomes.io is a private company.
What is the current stock price of Genomes.io?
Genomes.io is a private company with no public stock price. No recent secondary market data is available.
How much is Genomes.io worth (valuation)?
Genomes.io's valuation is estimated at $8.4M based on funding round data.
Can I buy Genomes.io stock?
Genomes.io shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Genomes.io's last funding round?
Genomes.io's most recent funding round was Strategic on September 30, 2019.
Who are the main investors in Genomes.io?
Key investors in Genomes.io include Modular Capital, Pantera Capital.
Will Genomes.io IPO soon?
No public IPO plans have been announced for Genomes.io.
How can I track Genomes.io secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Genomes.io's secondary market activity and sign up for updates.